Clinical and laboratory characteristics of patients having amyloidogenic transthyretin deposition in osteoarthritic knee joints

Journal of Zhejiang University: Science B

Volumn 15, Issue 1, 2014, Pages 92-99

  Gu, Ya Jun ^a   Ge, Peng ^a   Mu, Yun ^b   Lu, Jin Hai ^a   Zheng, Fang ^a   Sun, Xu Guo ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN CHILDREN S HOSPITAL   (China)

Author keywords

Amyloid; Immunoglobulin light chain; Matrix assisted laser desorption ionizaton time of flight mass spectrometry (MALDI TOF MS); Osteoarthritis; Transthyretin

Indexed keywords

AMYLOID PROTEIN; AMYLOIDOGENIC TRANSTHYRETIN; CONGO RED; IMMUNOGLOBULIN LIGHT CHAIN; PREALBUMIN; SERUM AMYLOID A; UNCLASSIFIED DRUG;

AGED; ARTICLE; BIREFRINGENCE; BLOOD ANALYSIS; CLINICAL ARTICLE; DISEASE DURATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE PROSTHESIS; LABORATORY TEST; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; SYNOVIUM; URINALYSIS; VERY ELDERLY; WILD TYPE;

AGED; AMYLOID NEUROPATHIES, FAMILIAL; BIOLOGICAL MARKERS; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PREALBUMIN; RANGE OF MOTION, ARTICULAR;

EID: 84893138276     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1300046     Document Type: Article

References (22)

1. Altman, R., Asch, E., Bloch, D., et al., 1986. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Arthritis Rheum., 29(8):1039-1049. [doi:10.1002/art.1780290816]
2. Benito, M.J., Veale, D.J., FitzGerald, O., et al., 2005. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis., 64(9):1263-1267. [doi:10.1136/ard.2004.025270]
3. Christensen, H.E., Sørenson, K.H., 1972. Local amyloid formation of capsula fibrosa in arthrosis coxae. Acta Pathol. Microbiol. Scand. Suppl., 233:128-131.
4. Cortez, L.M., Ávila, C.L., Torres Bugeau, C.M., et al., 2010. Glyceraldehyde-3-phosphate dehydrogenase tetramer dissociation and amyloid fibril formation induced by negatively charged membranes. FEBS Lett., 584(3):625-630. [doi:10.1016/j.febslet.2009.12.012]
5. Egan, M.S., Goldenberg, D.L., Cohen, A.S., et al., 1982. The association of amyloid deposits and osteoarthritis. Arthritis Rheum., 25(2):204-208. [doi:10.1002/art.1780250214]
6. El Mansoury, T.M., Hazenberg, B.P.C., El Badawy, S.A., et al., 2002. Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann. Rheum. Dis., 61(1):42-47. [doi:10.1136/ard.61.1.42]
7. Gorevic, P.D., Prelli, F.C., Wright, J., et al., 1989. Systemic senile amyloidosis. Identification of a new prealbumin (transthyretin) variant in cardiac tissue: immunologic and biochemical similarity to one form of familial amyloidotic polyneuropathy. J. Clin. Invest., 83(3):836-843. [doi:10.1172/JCI113966]
8. Hattori, T., Takei, Y., Koyama, J., et al., 2003. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid, 10(4):229-239. [doi:10.3109/13506120309041740]
9. 2 microglobulin related amyloidosis. Ann. Rheum. Dis., 48(5):409-420. [doi:10.1136/ard.48.5.409]
10. Ihse, E., Suhr, O.B., Hellman, U., et al., 2011. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J. Mol. Med., 89(2): 171-180. [doi:10.1007/s00109-010-0695-1]
11. Insall, J.N., Dorr, L.D., Scott, R.D., et al., 1989. Rationale of the Knee Society clinical rating system. Clin. Orthop. Relat. Res., 248:13-14.
12. Kingsbury, J.S., Klimtchuk, E.S., Théberge, R., et al., 2007. Expression, purification, and in vitro cysteine-10 modification of native sequence recombinant human transthyretin. Protein Express. Purif., 53(2):370-377. [doi:10.1016/j.pep.2007.01.004]
13. Kuroda, T., Tanabe, N., Sakatsume, M., et al., 2002. Comparison of gastroduodenal, renal and abdominal fat biopsies for diagnosing amyloidosis in rheumatoid arthritis. Clin. Rheumatol., 21(2):123-128. [doi:10.1007/PL00011217]
14. Ladefoged, C., 1983. Amyloid in osteoarthritic hip joints: deposits in relation to chondromatosis, pyrophosphate, and inflammatory cell infiltrate in the synovial membrane and fibrous capsule. Ann. Rheum. Dis., 42(6):659-664. [doi:10.1136/ard.42.6.659]
15. M'Bappé, P., Grateau, G., 2012. Osteo-articular manifestations of amyloidosis. Best Pract. Res. Clin. Rheumatol., 26(4): 459-475. [doi:10.1016/j.berh.2012.07.003]
16. Niggemeyer, O., Steinhagen, J., Deuretzbacher, G., et al., 2011. Amyloid deposition in osteoarthritis of the hip. Arch. Orthop. Trauma Surg., 131(5):637-643. [doi:10.1007/s00402-010-1187-z]
17. Ray, A., Ray, B.K., 2008. An inflammation-responsive transcription factor in the pathophysiology of osteoarthritis. Biorheology, 45(3-4):399-409. [doi:10.3233/BIR-2008-0500]
18. Sipe, J.D., Benson, M.D., Buxbaum, J.N., et al., 2012. Amyloid fibril protein nomenclature: 2012 recommendations from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid, 19(4):167-170. [doi:10.3109/13506129.2012.734345]
19. Solomon, A., Murphy, C.L., Kestler, D., et al., 2006. Amyloid contained in the knee joint meniscus is formed from apolipoprotein A-I. Arthritis Rheum., 54(11):3545-3550. [doi:10.1002/art.22201]
20. Sørenson, K.H., Christensen, H.E., 1973. Local amyloid formation in the hip joint capsule in osteoarthritis. Acta Orthop. Scand., 44(4):460-466.
21. Tachibana, N., Tokuda, T., Yoshida, K., et al., 1999. Usefulness of MALDUTOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy. Amyloid, 6(4):282-288. [doi:10.3109/13506129909007341]
22. Torres-Bugeau, C.M., Borsarelli, C.D., Minahk, C.J., et al., 2011. The key role of membranes in amyloid formation from a biophysical perspective. Curr. Protein Pept. Sci., 12(3):166-180. [doi:10.2174/138920311795860197]